Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,994 total articles

Viasat Announces Appointment of Shekar Ayyar and Jinhy Yoon to Board of Directors and Enters into Cooperation Agreement with Carronade Capital Management

Viasat Announces Appointment of Shekar Ayyar and Jinhy Yoon to Board of Directors and Enters into Cooperation Agreement with Carronade Capital Management

Viasat, Inc. has announced the appointment of Shekar Ayyar and Jinhy Yoon to its Board of Directors and Strategic Review Committee, aimed at strengthening the board with expertise in technology, finance, and governance. Concurrently, Viasat has entered a cooperation agreement with Carronade Capital Management, a significant shareholder advocating f…

Aduro Appoints Industry Veteran to Advance Petroleum Applications

Aduro Appoints Industry Veteran to Advance Petroleum Applications

Aduro Clean Technologies Inc. has appointed Scott Smith, an industry veteran with extensive experience in petroleum upgrading, as Program Director for Petroleum Technology Solutions. This strategic hire supports Aduro's advancement of its Hydrochemolytic™ Technology (HCT) in upgrading paraffinic crude oils and bitumen, progressing from lab validati…

DarkIris Inc. Announces 16 for 1 Share Consolidation

DarkIris Inc. Announces 16 for 1 Share Consolidation

DarkIris Inc., a Hong Kong-based mobile game developer and operator listed on Nasdaq, announced a 16-for-1 share consolidation effective May 11, 2026, to comply with Nasdaq listing standards and optimize its capital structure. This move aims to enhance institutional investor appeal and support the company's growth strategy, which includes leveragin…

vTv Therapeutics to Participate in Upcoming May Investor Conferences

vTv Therapeutics to Participate in Upcoming May Investor Conferences

vTv Therapeutics announced management's participation in two upcoming investor conferences in May 2026, highlighting their late-stage clinical development of cadisegliatin, an oral adjunctive therapy for type 1 diabetes currently in Phase 3 trials. The company plans to webcast fireside chats providing updates on their pipeline. Cadisegliatin has re…

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality

NRx Pharmaceuticals has received FDA clearance to begin a phase 2/3 clinical trial testing NRX-101 combined with Robotic-enabled Transcranial Magnetic Stimulation (TMS) versus placebo in patients with treatment-resistant depression and suicidality. The trial aims to enroll 240+ patients at academic, military, and clinical sites across the US. This …

ZenaTech To Enter Australian Market Through Drone as a Service Acquisition of an Established Land Surveying and Spatial Services Company Serving Government and Infrastructure Clients

ZenaTech To Enter Australian Market Through Drone as a Service Acquisition of an Established Land Surveying and Spatial Services Company Serving Government and Infrastructure Clients

ZenaTech, a Nasdaq-listed AI drone and Drone as a Service provider, announced its agreement to acquire a well-established Australian land surveying and spatial services company, marking its 22nd DaaS acquisition and entry into the Australian and Asia-Pacific markets. The acquisition enhances ZenaTech's presence in infrastructure, public works, and …

Inspired Reports First Quarter 2026 Results

Inspired Reports First Quarter 2026 Results

Inspired Entertainment, Inc. reported first quarter 2026 revenue of $57.2 million, with a 29% increase in Adjusted EBITDA to $23.7 million and a 41% margin. Despite a 5% revenue decline due to divestitures and restructuring, core business segments, particularly Interactive, showed strong growth—Interactive revenue grew 38% year-over-year. The compa…

Mobilicom to Showcase its Cybersecure Autonomous Solutions at Leading U.S. Industry Events—Xponential and Loitering Munitions USA

Mobilicom to Showcase its Cybersecure Autonomous Solutions at Leading U.S. Industry Events—Xponential and Loitering Munitions USA

Mobilicom Limited (Nasdaq: MOB) will participate in two significant U.S. events, XPONENTIAL 2026 and Loitering Munitions USA, showcasing its cybersecurity-focused autonomous drone and robotics solutions. CEO Oren Elkayam will present on preventing cascade failures in autonomous fleets, highlighting the company's innovation and role in secured auton…

ARKO Corp. Reports First Quarter 2026 Results

ARKO Corp. Reports First Quarter 2026 Results

ARKO Corp., a major U.S. convenience store operator and fuel wholesaler, reported improved Q1 2026 financials with net loss narrowing to $5.6 million from $12.7 million a year ago. Adjusted EBITDA surged 65.1% to $50.9 million driven by growth in merchandise margins and same-store fuel margins. The company made substantial progress in converting re…

BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

BriaCell Therapeutics announced the addition of NYU Langone Health's Perlmutter Cancer Center as a site for its pivotal Phase 3 clinical trial evaluating Bria-IMT™ immunotherapy in advanced metastatic breast cancer. The study tests Bria-IMT combined with an immune checkpoint inhibitor versus physician's choice treatment. The trial has FDA Fast Trac…

MACOM Reports Fiscal Second Quarter 2026 Financial Results

MACOM Reports Fiscal Second Quarter 2026 Financial Results

MACOM Technology Solutions Holdings, Inc. announced robust fiscal second quarter 2026 results, with revenue of $289 million, a 22.5% increase year-over-year, and strong margin expansion. Adjusted net income rose significantly to $84.3 million, or $1.09 per diluted share. The company projects continued growth for the fiscal third quarter with expect…

Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Black Diamond Therapeutics reported Q1 2026 results showcasing $118.3 million in cash and investments, sufficient to fund operations into late 2028. The company advanced its clinical-stage oncology drug, silevertinib, with key Phase 2 trial presentations scheduled at ASCO 2026, including data on frontline EGFRm NSCLC and newly diagnosed EGFRvIII+ G…